What does a ferritin of 10.8 ng/mL, serum iron of 45 µg/dL, total iron‑binding capacity of 360 µg/dL, and transferrin of 288 mg/dL indicate, and what is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Iron Deficiency Diagnosis and Management

These laboratory values indicate iron deficiency and require iron supplementation. The ferritin of 10.8 ng/mL is well below all diagnostic thresholds, confirming depleted iron stores regardless of patient demographics 1.

Laboratory Interpretation

Your patient's iron studies show a classic pattern of iron deficiency:

  • Ferritin 10.8 ng/mL: Severely low, diagnostic of iron deficiency in all populations

    • Below the 30 ng/mL threshold for adults 1
    • Below the 20 ng/mL threshold for children 1
    • Below the 30 ng/mL threshold for pregnant individuals 1
  • Transferrin saturation: 12.5% (calculated as 45/360 × 100)

    • Well below the 20% threshold, confirming iron-deficient erythropoiesis 1, 2
  • TIBC 360 µg/dL: Elevated, consistent with iron deficiency as the body attempts to capture more circulating iron 3

  • Serum iron 45 µg/dL: Low, reflecting inadequate circulating iron 3

This constellation—low ferritin, low transferrin saturation, elevated TIBC, and low serum iron—definitively establishes iron deficiency without inflammation 4, 2.

Identify the Underlying Cause

All adult men and postmenopausal women with these findings require bidirectional endoscopy to identify gastrointestinal bleeding sources 5. The decision for premenopausal women depends on menstrual history:

Key Historical Elements to Obtain:

  • Menstruating individuals: Assess for heavy menstrual bleeding (HMB) or abnormal uterine bleeding (AUB). If present, address the bleeding source while treating iron deficiency 1

  • Dietary assessment: Evaluate for restricted diets (vegan, vegetarian), inadequate iron intake 2

  • Malabsorption risk factors:

    • History of bariatric surgery (gastric bypass particularly impairs iron absorption) 5, 2
    • Celiac disease 2
    • Inflammatory bowel disease (13-90% prevalence of iron deficiency) 5, 2
    • Chronic use of proton pump inhibitors or antacids 1
    • Helicobacter pylori infection 1
  • Chronic inflammatory conditions: Heart failure (37-61% prevalence), chronic kidney disease (24-85% prevalence), cancer (18-82% prevalence) 2

  • Blood loss: NSAID use, blood donation history, parasitic infections 1, 2

Treatment Approach

First-Line: Oral Iron

Start with oral ferrous sulfate 325 mg daily or on alternate days 2. Alternate-day dosing may improve tolerability with similar efficacy.

Indications for Intravenous Iron (First-Line in Specific Populations):

Switch to intravenous iron if any of the following apply:

  • Oral iron intolerance (gastrointestinal side effects)
  • Malabsorption conditions: celiac disease, post-bariatric surgery 5, 2
  • Inflammatory bowel disease: Give strong consideration to IV iron as first-line therapy due to inflammation-related intestinal malabsorption 5
  • Chronic inflammatory conditions: CKD, heart failure, cancer 2
  • Ongoing significant blood loss 2
  • Pregnancy (second and third trimesters) 2

Common Pitfall to Avoid:

Do not rely on hemoglobin alone to assess response or need for treatment. Nonanemic iron deficiency (ferritin <30 ng/mL with normal hemoglobin) causes significant symptoms including fatigue, restless legs syndrome (32-40% prevalence), difficulty concentrating, exercise intolerance, and depression 2. These symptoms warrant treatment even without anemia.

Monitoring

Recheck ferritin after 8-12 weeks of oral iron therapy or 4-6 weeks after IV iron. Target ferritin levels:

  • General population: >30 ng/mL 1
  • Patients with ongoing risk factors or symptoms: >50 ng/mL 1
  • Pregnant individuals: >30 ng/mL (>50 ng/mL if anemic or high-risk) 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.